Qiagen Teams with Max Planck on TB MDx Test | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen today said that it will collaborate with the Max Planck Institute for Infection Biology's department of immunology to develop a molecular diagnostic test for tuberculosis.

Specifically, the partners will develop a test aimed at assessing the risk of an individual with latent TB developing active TB disease during his lifetime.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for RNA splicing in genetic variation, and more.

An advocacy group sues the US Food and Drug Administration over redactions of information about advisory committee members, Stat News reports.

Mexico is trying to lure young genomics researchers back home with their own labs, Science reports.

A molecular autopsy has aided a woman's search for why sudden cardiac death has stalked her family, the Wall Street Journal reports.